The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Masitinib plus gemcitabine as first-line treatment of pancreatic cancer with pain: Results from phase 3 study AB12005.
 
Joel EZENFIS
No Relationships to Disclose
 
Olivier Hermine
Employment - AB Science
Leadership - AB Science
Stock and Other Ownership Interests - AB Science
Honoraria - AB Science
Research Funding - AB Science
Patents, Royalties, Other Intellectual Property - Institut national de la santé et de la recherche médicale